Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm
Wei Wang, Jie Xu, Joseph D. Khoury, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3375-3375
Open Access | Times Cited: 25
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
NPM1 mutation frequency and protein in Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasms
Hanan Hamdan, Alexa J. Siddon, Maximiliano Ramia de, et al.
Human Pathology (2025), pp. 105766-105766
Closed Access
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
Axel Künstner, Julian Schwarting, Hanno M. Witte, et al.
Leukemia (2024) Vol. 38, Iss. 5, pp. 1086-1098
Open Access | Times Cited: 4
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Wei‐Ying Jen, Marina Konopleva, Naveen Pemmaraju
Cancer (2024) Vol. 130, Iss. 13, pp. 2260-2271
Closed Access | Times Cited: 4
Abgeschlagenheit und knotige Hautveränderungen bei einem 76-jährigen Mann
Nils Brökers, Julie Schanz
Springer eBooks (2025), pp. 197-201
Closed Access
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
Hannah C. Beird, C. Cameron Yin, Joseph D. Khoury, et al.
Blood Advances (2023) Vol. 7, Iss. 10, pp. 2000-2003
Open Access | Times Cited: 8
Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
Philipp Faustmann, Jan C. Schroeder, Lucas Mix, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7099-7099
Open Access | Times Cited: 2
Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
Axel Künstner, Julian Schwarting, Hanno M. Witte, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 11
Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Testicular Rosai-Dorfman disease clonally related to CMML – Case report and literature review
August Fiegl, Stefan Dirnhofer, Darius Juškevičius, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154548-154548
Open Access | Times Cited: 4
Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm
Yumeng Zhang, Lubomir Sokol
Cancer Management and Research (2022) Vol. Volume 14, pp. 2107-2117
Open Access | Times Cited: 7
Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review
Yavuz Şahin, Y. Lynn Wang, Jianming Pei, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 305-305
Open Access | Times Cited: 3
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Blastic plasmacytoid dendritic cell neoplasm in Jinhua, China: Two case reports
Jiawei Cai, Mengyao Li, Weihao Wang, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 22, pp. 5263-5270
Open Access
Advancing the understanding and management of blastic plasmacytoid dendritic cell neoplasm: Insights from recent case studies
Yan Luo, Lijuan Wang, Cheng-Long Wang
World Journal of Clinical Cases (2024) Vol. 12, Iss. 31, pp. 6441-6446
Closed Access
A diagnostic dilemma for a patient with skin lesions and marked leukocytosis: mixed phenotype acute leukaemia or blastic plasmacytoid dendritic cell neoplasm with aberrant cytoplasmic CD3 expression?
Zhihong Hu, C. Cameron Yin, Xiaoping Sun, et al.
Pathology (2024) Vol. 57, Iss. 3, pp. 371-374
Closed Access
A neonatal case of cutaneous blastic plasmacytoid dendritic cell neoplasm with transient regression
Yuan Fang, Yizhen Wang, Lian Chen
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 11
Closed Access
Blastic Plasmacytoid Dendritic Cell Neoplasm Presenting as Solitary Violaceous Thigh Plaque: Answer
Yazan Alhalaseh, Karthik Krishnamurthy, Dinesh Pradhan
American Journal of Dermatopathology (2024) Vol. 46, Iss. 12, pp. 878-879
Closed Access
Does H3K27me3 expression play a role in patients with Blastic plasmacytoid dendritic cell neoplasm? A clinicopathologic analysis of 14 patients
Kuai Yu, Gang Meng, Hong He, et al.
Annals of Diagnostic Pathology (2024) Vol. 74, pp. 152413-152413
Closed Access
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
Jasper X. Zheng, Elham Vali Betts, Denis M. Dwyre, et al.
Clinical Pathology (2024) Vol. 17
Open Access
Page 1 - Next Page

Scroll to top